サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1304163

月経痛治療市場：薬剤クラス別、タイプ別、投与経路別、剤形別、流通チャネル別、地域別- 市場規模、シェア、展望、機会分析、2023年～2030年

Menstrual Cramps Treatment Market, By Drug Class, By Type, By Route of Administration, By Dosage Form, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日
ページ情報
英文 205 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
月経痛治療市場：薬剤クラス別、タイプ別、投与経路別、剤形別、流通チャネル別、地域別- 市場規模、シェア、展望、機会分析、2023年～2030年
出版日: 2023年05月30日
発行: Coherent Market Insights
ページ情報: 英文 205 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

月経痛（月経困難症）とは、下腹部がズキズキしたり、けいれんするような痛みです。多くの女性は、月経直前や月経中に月経痛を起こします。子宮内膜症や子宮筋腫などの疾患が月経痛を引き起こすこともあります。下腹部の痛み、お腹の圧迫感、お尻や腰、太ももの内側の痛みなどの症状が現れます。月経痛の治療には、イブプロフェン（アドビル）、ナプロキセンナトリウム（アリーブ）などのNSAIDsのような市販の鎮痛剤が使われます。また、マイフェンブリー（ファイザー）などのホルモン拮抗薬も月経痛の治療に用いられます。

市場力学

市場のプレーヤーは、月経痛治療のためのコラボレーションなどの無機的な戦略の増加に注力しており、予測期間にわたって世界の月経けいれん市場の成長を促進すると予想されます。例えば、2018年4月10日、世界の研究開発型バイオ医薬品企業であるAbbVie社とNeurocrine Biosciences社は、子宮内膜症関連痛におけるElagolixのPDUFA（処方薬ユーザーフィー法）を発表しました。エラゴリックスは、ゴナドトロピン放出ホルモン（GnRH）受容体拮抗薬です。経口投与され、下垂体の内因性GnRH受容体を遮断する短時間作用型の分子です。

生理痛の有病率の増加は、予測期間中の市場成長を促進すると予想されます。例えば、2022年1月14日、MDPIが発表した記事によると、欧州のルーマニアで前向き、分析的、観察的研究が実施され、2019年11月7日から2020年1月30日の間に行われました。この研究には、同国内の5つの大学センターから1720人が参加しました。1,720人の参加者のうち、1,349人（78.4％）が月経困難症でした。月経困難症の有病率は16％から91％であったと報告されています。最も多く使用された薬剤は非ステロイド性抗炎症薬で、741人（54.9％）が使用していました。

また、International Journal of Womens Health誌に掲載された論文によると、エチオピア南部で実施された研究では、女子学生全体の原発性月経困難症の有病率は、報告された人口の70％でした。

本調査の主な特徴

  • 本レポートでは、世界の月経痛治療市場を詳細に分析し、2022年を基準年とした予測期間（2023-2030年）の市場規模および年間平均成長率（CAGR%）を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場に対する魅力的な投資提案のマトリックスについて解説しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要ハイライト、財務実績、戦略などのパラメータに基づいて、世界の月経痛治療市場の主要企業をプロファイルしています。
  • 本調査の対象となる主要企業には、Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co.（Pvt.）Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine（Nanjing）Co., Ltd.が含まれます。
  • 本レポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。
  • 世界の生理痛治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
  • 利害関係者は、世界の月経痛治療薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場概況

  • レポート概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • コヒーレント・オポチュニティ・マップ（COM）

第3章 市場力学、規制、動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場魅力度分析
    • 市場機会
  • 製品発表
  • 市場動向
  • 合併、買収、提携
  • 規制ガイドラインとコンプライアンス
  • 主な発展
  • PEST分析
  • 技術情勢
  • 価格分析
  • ブランド分析
  • 投資と資金調達
  • 施設の拡張

第4章 月経痛治療の世界市場：コロナウイルス（COVID-19）流行の影響

  • 政府の取り組み
  • COVID-19疫学
  • 主な発展

第5章 月経痛治療の世界市場：薬剤クラス別、2018年～2030年

  • 鎮痛薬
  • 抗コリン薬
  • 非ステロイド性抗炎症薬
  • 血行促進薬
  • その他（特に黄体ホルモン剤）

第6章 月経痛治療の世界市場：タイプ別、2018年～2030年

  • 原発性月経困難症
  • 続発性月経困難症

第7章 月経痛治療薬の世界市場：投与経路別、2018年～2030年

  • 経口剤
  • 注射剤
  • 局所
  • その他（子宮内、その他）

第8章 月経痛治療の世界市場：剤形別、2018年～2030年

  • 錠剤
  • カプセル剤
  • 懸濁液
  • その他（経皮パッチ、その他）

第9章 月経痛治療の世界市場：流通チャネル別、2018年～2030年

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 月経痛治療の世界市場：地域別、2018年～2030年

  • 北米
  • 米国
  • カナダ
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
  • 欧州
  • 英国
  • ドイツ
  • イタリア
  • フランス
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • 中国
  • インド
  • 日本
  • ASEAN
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
  • 中東
  • GCC
  • イスラエル
  • その他中東
  • アフリカ
  • 北アフリカ
  • 中央アフリカ
  • 南アフリカ

第11章 競合情勢

  • Pfizer, Inc.
  • Ingelheim International GmbH
  • Bayer AG
  • Abbott
  • Cipla Inc
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Reddy's Laboratories Ltd
  • Almatica Pharma LLC.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Eisen Pharmaceutical Co.（Pvt.）Ltd
  • Emcure Pharmaceuticals
  • AbbVie
  • Sparsha Pharma International Pvt Ltd.
  • Hope Medicine（Nanjing）Co., Ltd

第12章 セクション

  • 調査手法
  • 出版社について
目次
Product Code: CMI5760

Menstrual cramps (dysmenorrhea) are throbbing or cramping pains in the lower abdomen. Many women have menstrual cramps just before and during their menstrual periods. Conditions such as endometriosis or uterine fibroids can cause menstrual cramps. Symptoms occurred like aching pain in lower abdomen, a feeling of pressure in belly, pain in hips, lower back, and inner thighs. To treat menstrual cramps, over-the-counter pain relievers such as NSAID's like ibuprofen (Advil), Naproxen sodium (Aleve) are used. Hormonal antagonists drugs such as MYFEMBREE (Pfizer) also used for the treatment of menstrual cramps.

Market Dynamics

Market players in the market are focusing on ncreasing inorganic strategies such as collaboration for menstrual cramp treatment is expected to drive the the global menstrual cramp market growth over the forecast period. For instance, on April 10, 2018, AbbVie, a global research and development-based biopharmaceutical company, and Neurocrine Biosciences, announced PDUFA (Prescription Drug User Fee Act) for Elagolix in endometriosis-associated pain.. Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It is administered orally, and is a short-acting molecule that blocks endogenous GnRH receptors in the pituitary gland.

Increasing prevalence of menstrual cramps is expected to drive the market growth over the forecast period. For instance, on January 14, 2022, article published by MDPI, stated that a study was conducted in Europe's Romania in prospective, analytical, observational and took place between 7 November 2019 and 30 January 2020. This study included a population of 1720 from five university centers throughout the country. Out of 1,720 participants, 1,349 (78.4%) had dysmenorrhea. The prevalence of dysmenorrhea, ranging from 16% to 91% has been reported. The most widely used drugs were non-steroidal anti-inflammatory drugs, utilized by 741 students (54.9%) has been reported.

Moreover, according to article published by International Journal of Womens Health, a study was conducted in Southern Ethiopia, the prevalence of primary dysmenorrhea among all the female students is 70% of population who reported.

Key features of the study:

  • This report provides in-depth analysis of the global menstrual cramps treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global menstrual cramps treatment market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co. (Pvt.) Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine (Nanjing) Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global menstrual cramps treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menstrual cramps treatments market

Detailed Segmentation:

  • Global Menstrual Cramp Treatment Market, By Drug Class:
    • Analgesics
    • Anticholinergic
    • Non-steroidal anti-inflammatory drugs (NSAIDs)
    • Haematinics
    • Others (Progestins, Among others)
  • Global Menstrual Cramp Treatment Market, By Type:
    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • Global Menstrual Cramp Treatment Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
    • Others (Intrauterine, Others)
  • Global Menstrual Cramp Treatment Market, By Dosage Form:
    • Tablet
    • Capsules
    • Suspension
    • Others (Transdermal Patch, Among others)
  • Global Menstrual Cramp Treatment Market, By Distribution channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Menstrual Cramps Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Pfizer Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ingelheim International GmbH PerkinElmer Inc.
    • Bayer AG
    • Abbott.
    • Cipla Inc
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Johnson & Johnson Services, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Almatica Pharma LLC.
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline Plc
    • Eisen Pharmaceutical Co. (Pvt.) Ltd.
    • Emcure Pharmaceuticals
    • AbbVie.
    • Sparsha Pharma International Pvt Ltd.
    • Hope Medicine (Nanjing) Co., Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Type
    • Market Snapshot, By Route of administration
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Market Trends
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Pricing Analysis
  • Brand Analysis
  • Investments and Funding
  • Facility Expansions

4. Global Menstrual Cramps Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Government Initiatives
  • COVID-19 Epidemiology
  • Key Developments

5. Global Menstrual Cramps Treatment Market, By Drug Class, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Anticholinergics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Non-steriodal anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Haematinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Progestins, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Menstrual Cramps Treatment Market, By Type, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Primary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Secondary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Menstrual Cramps Treatment Market, By Route of administration, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segments Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Intrauterine, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Menstrual Cramps Treatment Market, By Dosage Form, 2018 - 2030, (US$ Million)

  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Transdermal Patch, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Global Menstrual Cramps Treatment Market, By Distribution channel, 2018 - 2030, (US$ Million)

  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Global Menstrual Cramps Treatment Market, By Region, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cipla Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Reddy's Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Almatica Pharma LLC.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisen Pharmaceutical Co. (Pvt.) Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emcure Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sparsha Pharma International Pvt Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hope Medicine (Nanjing) Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

12. Section

  • Research Methodology
  • About Us